{
    "clinical_study": {
        "@rank": "45082", 
        "arm_group": [
            {
                "arm_group_label": "Low dose mavrilimumab + MTX", 
                "arm_group_type": "Active Comparator", 
                "description": "GM-CSFR alpha inhibitor"
            }, 
            {
                "arm_group_label": "Medium dose mavrilimumab + MTX", 
                "arm_group_type": "Active Comparator", 
                "description": "GM-CSFR alpha inhibitor"
            }, 
            {
                "arm_group_label": "High dose mavrilimumab + MTX", 
                "arm_group_type": "Active Comparator", 
                "description": "GM-CSFR alpha inhibitor"
            }, 
            {
                "arm_group_label": "Placebo Q2W + MTX", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if mavrilimumab can provide benefit to subjects with\n      rheumatoid arthritis."
        }, 
        "brief_title": "A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "Despite the therapeutic improvements with recent biologic agents approved for rheumatoid\n      arthritis, there is still significant unmet medical need for the treatment of subjects with\n      this chronic disease to achieve a faster, more complete response, and higher rates of\n      remission. The aim of the study is to explore the optimum dose of mavrilimumab for further\n      clinical development and more fully investigate the efficacy and safety profile of\n      mavrilimumab after longer drug exposure (ie, 24 weeks). The results of this study will form\n      the basis for future clinical studies with mavrilimumab."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A diagnosis of adult onset RA in line with the protocol\n\n          -  Moderately active disease in line with the protocol\n\n          -  A pre-defined number of swollen joints in line with the protocol\n\n          -  Inadequate response to one or more conventional DMARDs\n\n          -  No evidence of respiratory disease\n\n        Exclusion Criteria:\n\n          -  A rheumatic autoimmune disease other than RA, or significant systemic extra-articular\n             involvement secondary to RA\n\n          -  A history of, or current, inflammatory joint disease other than RA\n\n          -  Previous treatment with the investigational drug\n\n          -  Discontinuation of a biologic DMARD due to lack of efficacy.\n\n          -  Non-compliant concurrent medications\n\n          -  Non-compliance with medical history criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "422", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706926", 
            "org_study_id": "CD-IA-CAM-3001-1071"
        }, 
        "intervention": {
            "arm_group_label": [
                "Low dose mavrilimumab + MTX", 
                "Medium dose mavrilimumab + MTX", 
                "High dose mavrilimumab + MTX", 
                "Placebo Q2W + MTX"
            ], 
            "description": "GM-CSFR alpha inhibitor", 
            "intervention_name": "Mavrilimumab or placebo subcutaneous Injection", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Antibodies, Monoclonal"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 9, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ciudad Autonoma de Buenos Aire", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Miguel de Tucuman", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plovdiv", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vina del Mar", 
                        "country": "Chile"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barranquilla", 
                        "country": "Colombia"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bogota", 
                        "country": "Colombia"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bruntal", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jihlava", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ostrava - Trebovice", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 2", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 4", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 4 - Krc", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zlin", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tallinn", 
                        "country": "Estonia"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hildesheim", 
                        "country": "Germany"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debrecen", 
                        "country": "Hungary"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gdynia", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grodzisk Mazowiecki", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Katowice", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wroclaw", 
                        "country": "Poland"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barnaul", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kazan", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Novosibirsk", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Niska Banja", 
                        "country": "Serbia"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durban", 
                        "country": "South Africa"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago de Compostela", 
                        "country": "Spain"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Donetsk", 
                        "country": "Ukraine"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kharkiv", 
                        "country": "Ukraine"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kiev", 
                        "country": "Ukraine"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lutsk", 
                        "country": "Ukraine"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vinnytsia", 
                        "country": "Ukraine"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Argentina", 
                "Bulgaria", 
                "Chile", 
                "Colombia", 
                "Czech Republic", 
                "Estonia", 
                "France", 
                "Germany", 
                "Hungary", 
                "Mexico", 
                "Poland", 
                "Russian Federation", 
                "Serbia", 
                "South Africa", 
                "Spain", 
                "Ukraine"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase 2b Study to Evaluate the Efficacy and Safety of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "DAS28(CRP)", 
                "measure": "Change from baseline in disease activity score", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "ACR critieria", 
                "measure": "Proportion of subjects showing an improvement", 
                "safety_issue": "No", 
                "time_frame": "Week 24"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706926"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Incidence of adverse events (AEs) and serious adverse events (SAEs). Laboratory measurements, vital signs, PFTs and dysnoea scores", 
                "measure": "Safety and Tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "Informed consent through to end of subject participation in the study, approximately 40 weeks"
            }, 
            {
                "description": "ACR20, ACR50, ACR70, ACRn, DAS28 Eular response", 
                "measure": "The response rates acheived at each visit", 
                "safety_issue": "No", 
                "time_frame": "Biweekly for 24 weeks"
            }, 
            {
                "description": "Using patient reported outcomes, patiemt assessment of pain and FACIT-fatigue", 
                "measure": "Effect of Mavrilimumab on Pain and Fatigue", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mavrilimumab serum concentrations", 
                "measure": "Pharmacokinetics (PK)", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 to Week 24"
            }, 
            {
                "description": "Number of subjects with anti-drug antibodies against mavrilimumab", 
                "measure": "Immunogenicity (IM)", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 to Week 24"
            }, 
            {
                "description": "DAS28", 
                "measure": "Remission and low diease activity rates", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "MedImmune LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "MedImmune LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}